Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System

Starting soon

Conditions studied: Hysterectomy, Benign Uterine Diseases

In brief

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

Key facts

Study ID

NCT07746531

Run by

Distalmotion SA

People needed

112

Starts

2026-08-07

Expected to finish

2028-12-01

Last updated by the study team

2026-08-05

Who can join

Age: 22 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patient is ≥ 22 years of age at time of enrollment/consent
• Patient is planned to undergo robotic-assisted and laparoscopic hysterectomy for benign disease
• Patient agrees to perform the 6-week follow-up assessment as per standard of care

You may not qualify if…

• Any planned concomitant procedures (not including salpingectomy and/or oophorectomy)
• Diagnosed malignant disease on reproductive organs
• Uterus myomatous with fibroid > 10cm

Where it is running

• Cypress surgery center — Wichita, Kansas, United States
• Memorial Hermann-Texas Medical Center - UT Health Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.